Pediatrics – Rheumatology
2ry analysis of a RCT | Vitamin D supplementation did not influence growth, body composition, and pubertal development in children.
30 Nov, 2022 | 13:49h | UTCInfluence of Vitamin D Supplementation on Growth, Body Composition, and Pubertal Development Among School-aged Children in an Area With a High Prevalence of Vitamin D Deficiency: A Randomized Clinical Trial – JAMA Pediatrics (free for a limited period)
Commentary: Vitamin D Supplementation Does Not Influence Growth in Children – HealthDay
Recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis.
3 Nov, 2022 | 14:01h | UTC
RCT | Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis.
15 Aug, 2022 | 12:05h | UTC
EULAR/ACR points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases.
24 Jun, 2022 | 11:23h | UTC
EULAR/PRES recommendations for vaccination of pediatric patients with autoimmune inflammatory rheumatic diseases.
24 Jun, 2022 | 11:17h | UTC
Consensus Paper: Diagnosis and treat-to-target management of macrophage activation syndrome in children.
24 Jun, 2022 | 11:13h | UTC
Cohort Study: Association of maternal autoimmune diseases with risk of mental disorders in offspring in Denmark.
20 Apr, 2022 | 09:19h | UTC
Commentary on Twitter
https://twitter.com/JAMANetworkOpen/status/1515057370715594753
RCT: Long-term efficacy and safety of up to 108 weeks of Ixekizumab in pediatric patients with moderate to severe plaque psoriasis.
18 Apr, 2022 | 09:49h | UTC
Commentary on Twitter
In this RCT, by 108 weeks of use of ixekizumab for pediatric psoriasis, PASI 75/90/100 were achieved in 92%/79%/55%, respectively, of children, with clearance of nails in 68%, scalp in 76%, genital lesions in 88%, and palm/sole involvement in 90%. https://t.co/vk73Z3MKi4
— JAMA Dermatology (@JAMADerm) April 13, 2022
Cohort Study: Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection.
12 Apr, 2022 | 09:57h | UTCCommentary: Older Kids More Vulnerable to MIS-C: Study – HealthDay
Acute phase of Kawasaki disease: a review of national guideline recommendations.
12 Apr, 2022 | 08:32h | UTC
Systematic Review: Epidemiology of musculoskeletal manifestations in pediatric inflammatory bowel disease.
7 Apr, 2022 | 07:55h | UTC
BSR guideline on management of pediatric, adolescent and adult patients with idiopathic inflammatory myopathy.
4 Apr, 2022 | 01:05h | UTC
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
1 Apr, 2022 | 08:45h | UTCCommentary: Network meta-analysis rates treatments for Kawasaki disease – medwire News
Guideline: Treatment of unspecific back pain in children and adolescents.
29 Mar, 2022 | 09:52h | UTC
ACR/Vasculitis Foundation Guideline for the management of Kawasaki Disease.
9 Mar, 2022 | 10:01h | UTC
ACR Guidelines for the Treatment of Juvenile Idiopathic Arthritis.
4 Mar, 2022 | 08:58h | UTC
What’s New in Pediatric Orthopedics.
25 Feb, 2022 | 10:48h | UTCWhat’s New in Pediatric Orthopaedics – The Journal of Bone & Joint Surgery
Anti-inflammatory treatment of Kawasaki Disease: comparison of current guidelines and perspectives.
25 Feb, 2022 | 10:29h | UTC
Review: Juvenile idiopathic arthritis.
28 Jan, 2022 | 08:13h | UTCJuvenile idiopathic arthritis – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Infographic: Juvenile idiopathic arthritis (if the link is paywalled, try this one)
Commentary on Twitter
Get Primed on juvenile idiopathic #arthritis with our NEW PrimeView! FREE to download this week!https://t.co/MUVlIRWCfY pic.twitter.com/G5woxpOlKI
— Nature Reviews Disease Primers (@DiseasePrimers) January 27, 2022
Review: Treatment of multisystem inflammatory syndrome (MIS-C) in children and adolescents.
18 Jan, 2022 | 09:46h | UTCTreatment of MIS-C in Children and Adolescents – Current Pediatrics Reports
Related:
Review of 4,470 cases of Multisystem Inflammatory Syndrome in Children in the US.
An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.
Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.
Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.
Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children
Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)
SR: Multisystem inflammatory syndrome in children related to COVID-19
Systematic Review: Foot orthoses for treating pediatric flat feet.
18 Jan, 2022 | 09:16h | UTCFoot orthoses for treating paediatric flat feet – Cochrane Library
Summary: Foot orthoses for treating flat feet in children – Cochrane Library
In a study with 1110 children with prolonged fever, MRP8/14 serum levels were validated as a diagnostic marker for systemic juvenile idiopathic arthritis.
14 Jan, 2022 | 08:07h | UTCMRP8/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever – Rheumatology (link to abstract – $ for full-text)
Commentary: It is about time: the first validated biomarker for early diagnosis of sJIA – Rheumatology
Imaging in non-bacterial osteomyelitis in children and adolescents: diagnosis, differential diagnosis and follow-up—an educational review based on a literature survey and own clinical experiences.
6 Oct, 2021 | 08:43h | UTC
Opinion | Amplified Pain Syndrome—An Insupportable Assumption
10 Mar, 2021 | 08:13h | UTCAmplified Pain Syndrome—An Insupportable Assumption – JAMA Pediatrics
Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)
23 Feb, 2021 | 01:57h | UTC